Skip to content
GenoLensGenoLens

GANAB

Chr 11q12.3

glucosidase II alpha subunit

Aliases:
GluII, G2AN, KIAA0088, GIIA, GIIalpha
MANE:
ENST00000356638.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Cystic kidney disease

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Ductal plate malformation

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Polycystic liver disease

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • polycystic kidney disease 3 with or without polycystic liver disease

    0.79
  • autosomal dominant polycystic liver disease

    0.51
  • Isolated polycystic liver disease

    0.51
  • autosomal dominant polycystic kidney disease

    0.47
  • Biliary tract abnormality

    0.44
  • COVID-19

    0.37
  • severe acute respiratory syndrome

    0.37
  • hereditary disease

    0.19
  • phototoxic dermatitis

    0.15
  • mathematical ability

    0.14

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Neutral alpha-glucosidase AB

Catalytic subunit of glucosidase II that cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the Glc(2)Man(9)GlcNAc(2) oligosaccharide precursor of immature glycoproteins (PubMed:10929008). Required for PKD1/Polycystin-1 and PKD2/Polycystin-2 maturation and localization to the cell surface and cilia (PubMed:27259053)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.